Sun Dianqin, Mülder Duco T, Li Yige, Nieboer Daan, Park Jin Young, Suh Mina, Hamashima Chisato, Han Weiran, O'Mahony James F, Lansdorp-Vogelaar Iris
Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Gastroenterology. 2024 Mar;166(3):503-514. doi: 10.1053/j.gastro.2023.11.286. Epub 2023 Nov 24.
BACKGROUND & AIMS: Nationwide organized gastric cancer (GC) screening programs have been running for decades in South Korea and Japan. This study conducted a quasi-experimental analysis to assess the population impact of these programs on GC mortality.
We used the flexible synthetic control method (SCM) to estimate the effect of the screening programs on age-standardized GC mortality and other upper gastrointestinal (UGI) diseases (esophageal cancer and peptic ulcer) among people aged ≥40 years. World Health Organization mortality data and country-level covariates from the World Bank and the Global Burden of Diseases study were used for the analyses. We compared postintervention trends in outcome with the counterfactual trend of the synthetic control and estimated average postintervention rate ratios (RRs) with associated 95% confidence intervals (CIs). A series of sensitivity analyses were conducted.
The preintervention fits were acceptable for the analyses of South Korea and Japan's GC mortality but poor for Japan's other UGI disease mortality. The average postintervention RRs were 0.83 (95% CI, 0.71-0.96) for GC mortality and 0.72 (95% CI, 0.57-0.90) for other UGI disease mortality in South Korea. The RR reached 0.59 by the 15th year after the initiation of nationwide screening. For Japan, the average RRs were 0.97 (95% CI, 0.88-1.07) for GC mortality and 0.93 (95% CI, 0.68-1.28) for other UGI disease mortality. Sensitivity analysis reveals the result for Japan may potentially be biased.
South Korea's nationwide GC screening has apparent benefits, whereas the Japanese program's effectiveness is uncertain. The experiences of South Korea and Japan could serve as a reference for other countries.
韩国和日本开展全国性胃癌(GC)筛查项目已有数十年。本研究进行了一项准实验分析,以评估这些项目对GC死亡率的人群影响。
我们使用灵活的合成对照法(SCM)来估计筛查项目对40岁及以上人群年龄标准化GC死亡率和其他上消化道(UGI)疾病(食管癌和消化性溃疡)的影响。分析使用了世界卫生组织的死亡率数据以及来自世界银行和全球疾病负担研究的国家级协变量。我们将干预后的结果趋势与合成对照的反事实趋势进行比较,并估计干预后的平均率比(RRs)及相关的95%置信区间(CIs)。进行了一系列敏感性分析。
韩国和日本GC死亡率分析的干预前拟合可接受,但日本其他UGI疾病死亡率的拟合较差。韩国GC死亡率的干预后平均RRs为0.83(95%CI,0.71 - 0.96),其他UGI疾病死亡率的为0.72(95%CI,0.57 - 0.90)。在全国筛查开始后的第15年,RR降至0.59。对于日本,GC死亡率的平均RRs为0.97(95%CI,0.88 - 1.07),其他UGI疾病死亡率的为0.93(95%CI,0.68 - 1.28)。敏感性分析表明日本的结果可能存在偏差。
韩国的全国性GC筛查有明显益处,而日本项目的有效性尚不确定。韩国和日本的经验可为其他国家提供参考。